These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37899190)

  • 1. [Diagnosis and treatment of autoimmune acquired coagulation factor deficiency].
    Ogawa Y
    Rinsho Ketsueki; 2023; 64(9):1116-1123. PubMed ID: 37899190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired hemophilia A: a review of recent data and new therapeutic options.
    Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM
    Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune-mediated acquired coagulation factor deficiencies: state-of-the-art in diagnosis and management].
    Ichinose A
    Rinsho Ketsueki; 2019; 60(6):667-679. PubMed ID: 31281160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.
    Sakurai Y; Takeda T
    J Immunol Res; 2014; 2014():320674. PubMed ID: 24741588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complications and their management in inherited and acquired bleeding disorders.
    Arruda VR; Lillicrap D; Herzog RW
    Blood; 2022 Sep; 140(10):1075-1085. PubMed ID: 35793465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development.
    Osaki T; Souri M; Ichinose A
    Int J Hematol; 2022 May; 115(5):672-685. PubMed ID: 35143024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy.
    Cugno M; Gualtierotti R; Tedeschi A; Meroni PL
    Autoimmun Rev; 2014 Jan; 13(1):40-8. PubMed ID: 23954454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.
    Kumar R; Carcao M
    Pediatr Clin North Am; 2013 Dec; 60(6):1419-41. PubMed ID: 24237980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: A single-center analysis.
    Osaki T; Souri M; Ogawa Y; Sato H; Mitsui T; Ichinose A
    Thromb Res; 2022 May; 213():154-162. PubMed ID: 35378421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice.
    Ichinose A; Osaki T; Souri M
    Semin Thromb Hemost; 2024 Jun; ():. PubMed ID: 38866039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of acquired hemophilia A onset during pregnancy: A case report.
    Nishi A; Muramatsu A; Maeda E; Kobayashi T; Waratani M; Kitawaki J
    J Obstet Gynaecol Res; 2021 Nov; 47(11):4060-4066. PubMed ID: 34263499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
    Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
    Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired hemophilia A: an underdiagnosed, severe bleeding disorder.
    Zdziarska J; Musiał J
    Pol Arch Med Wewn; 2014; 124(4):200-6. PubMed ID: 24658664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and laboratory monitoring of hemophilia A.
    Platton S; Sivapalaratnam S; Raheja P
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):11-18. PubMed ID: 38066923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.
    Coppola A; Favaloro EJ; Tufano A; Di Minno MN; Cerbone AM; Franchini M
    Semin Thromb Hemost; 2012 Jul; 38(5):433-46. PubMed ID: 22740182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory, clinical and therapeutic aspects of acquired hemophilia A.
    Franchini M; Targher G; Montagnana M; Lippi G
    Clin Chim Acta; 2008 Sep; 395(1-2):14-8. PubMed ID: 18505682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired bleeding disorders.
    Tiede A; Zieger B; Lisman T
    Haemophilia; 2022 May; 28 Suppl 4():68-76. PubMed ID: 35521729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and open issues in the management of acquired hemophilia A (AHA).
    Shetty SD; Ghosh K
    Blood Cells Mol Dis; 2015 Mar; 54(3):275-80. PubMed ID: 25486929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired factor VIII inhibitors.
    Franchini M; Lippi G
    Blood; 2008 Jul; 112(2):250-5. PubMed ID: 18463353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold?
    Franchini M; Schiavulli M; Liumbruno GM
    Expert Rev Hematol; 2021 Mar; 14(3):263-270. PubMed ID: 33655810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.